7751:TSECanon Inc. Analysis
Data as of 2026-06-12 - not real-time
¥4,273.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Canon Inc. (7751.T) trades at ¥4,273, just below its 20‑day SMA of ¥4,275.4 and modestly under its 50‑day SMA of ¥4,291.6, indicating a short‑term price compression near key moving averages. Technical signals are mixed: the MACD histogram is positive (≈¥3.33) and the MACD line sits above the signal line, suggesting bullish momentum, yet the broader trend remains bearish and volume is decreasing, with the price hovering between the identified support at ¥4,116 and resistance at ¥4,447. Fundamentally, Canon appears attractively priced – its trailing P/E of 11.6 is far below the industry average of 36.8, and the dividend yield of 3.74% with a 43.6% payout ratio is supported by strong operating cash flow (¥428 bn) and free cash flow (¥68.8 bn). The DCF‑derived fair value of ¥525 is dramatically lower than the market price, creating a tension between absolute and relative valuation, but the upside/downside estimate of +12.3% suggests modest upside potential. Recent product news, such as the EOS R6 V launch, could provide a short‑term catalyst for the imaging segment, while the diversified portfolio across printing, medical, and industrial equipment underpins longer‑term stability. With a low beta of 0.14, 30‑day volatility of 20%, and a solid balance sheet (debt‑to‑equity 33.7%), Canon presents a balanced risk‑return profile suitable for value‑oriented investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram despite bearish trend
- Price near key support level
- Decreasing volume indicating potential consolidation
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Low P/E relative to industry peers
- Attractive dividend yield with sustainable payout
- Upside potential of ~12% based on valuation model
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified business segments reducing cyclical exposure
- Strong cash generation and modest leverage
- Consistent dividend policy supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin6.61%
P/E Ratio11.6
ROE9.37%
ROA4.54%
Debt/Equity33.70
P/B Ratio1.1
Op. Cash Flow¥428.5B
Free Cash Flow¥68.8B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI48.8
Support¥4,116.00
Resistance¥4,447.00
MA 20¥4,275.40
MA 50¥4,291.60
MA 200¥4,476.03
MACDBullish
VolumeDecreasing
Fear & Greed Index88.68
Valuation
Fair Value¥524.83
Target Price¥4,800.00
Upside/Downside12.33%
GradeFair
TypeValue
Dividend Yield3.74%
Risk Assessment
Beta0.14
Volatility20.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.